Combined system-level interaction: immune modulation and antibacterial activity

The term Combined system-level interaction: immune modulation and antibacterial activity refers to a multi-faceted therapeutic approach rather than a single protein or receptor. This strategy aims to combat bacterial infections by simultaneously enhancing the host's innate or adaptive immune defenses while exerting direct antimicrobial pressure on the pathogen. Such interactions are often studied in the context of host-directed therapies (HDTs), where drugs may target host pathways like autophagy, cytokine production, or macrophage activation to improve the clearance of multi-drug resistant bacteria. Because it represents a complex interplay between host signaling networks and microbial survival mechanisms, it is classified as a system-level interaction rather than a discrete molecular target. This approach is particularly relevant in treating chronic infections, sepsis, and pathogens that evade the immune system, such as Mycobacterium tuberculosis.

Other names

Host-directed therapy for bacterial infectionImmunomodulatory antibacterial strategyDual-action antimicrobial modulation

This entry describes a therapeutic strategy or a system-level biological effect rather than a single molecular target. It involves the simultaneous modulation of the host immune system (e.g., via cytokines or pattern recognition receptors) and the direct inhibition of bacterial growth or survival.